Upcoming speakers
Previous speakers
6 May
Charles Keller
Children's Cancer Therapy Development Institute
Machine Learning for rhabdomyosarcoma subtype diagnosis (a research study with international aspirations)
Twitter: @cctdilab
13 May
Joshua Waterfall
Institut Curie
Deep learning and transcriptomic profiling for sarcoma diagnosis
Twitter: @joshwaterfall
18 May
Brian Van Tine
Washington University in St. Louis
Sarcoma Metabolism
Please note this webinar is on a Monday
Twitter: @bvantine1
27 May
David Kirsch
Duke University
Opportunities and challenges of using immunotherapy in soft tissue sarcomas
Twitter: @DKirschMDPhD
5 June
Kevin Jones
Huntsman Cancer Institute
The genetics of translocation-associated sarcomagenesis
Please note this webinar is on a Friday
10 June
David Drewry
University of North Carolina at Chapel Hill
Drug Discovery strategies for Chordoma: Vulnerability identification and vulnerability targeting
Twitter: @dhdrewry
1 July
Matthew Blackledge
The Institute of Cancer Research
Artificial Intelligence and quantitative imaging: a new paradigm for sarcoma response assessment?
Twitter: @blackledgeICR
8 July
Thomas Grünewald
German Cancer Research Center
Targeting developmental pathways in Ewing sarcoma
Twitter: @GrunewaldLab
13 July
Nischalan Pillay
University College London Cancer Institute
The copy number signature landscape of sarcomas
Please note this webinar is on a Monday
Twitter: @NischalanP
22 July
Jacob Scott
Cleveland Clinic - Learner Research Institute
Identifying states of collateral sensitivity during the evolution of therapeutic resistance in Ewing’s sarcoma using experimental evolution and mathematical modeling
Twitter: @CancerConnector
29 July
Javed Khan
National Cancer Institute
Exploring and targeting the epigenome of fusion positive rhabdomyosarcoma
Twitter: @khanjavNCI
5 August
Jesse Boehm
Broad Institute
Systematic approaches to create and perturb patient-derived models of rare tumors
Twitter: @boehmjesse
12 August
Angela Hirbe
Washington University in St. Louis
Advancing therapy for NF1 and sporadic MPNST: The role of genomics and novel models
17 August
Judith Bovée
Leiden University
Sarcoma modeling for patient specific treatment
Please note this webinar is on a Monday
26 August
Sebastian Bauer
Universitätsklinikum Essen
TKI-resistance in KIT/PDGFRA-mutant GIST – molecular mechanisms and implications for salvage treatments
Twitter: @seppobauer
9 September
Matthew Hemming
Dana-Farber Cancer Institute
Anatomic and transcriptional determinants of gastrointestinal stromal tumour
16 September
Paul Huang
The Institute of Cancer Research
Optimising kinase inhibitor therapy in soft tissue sarcomas
Twitter: @HuanglabICR
23 September
Benjamin Nacev
Memorial Sloan Kettering Cancer Center
Histone mutations in sarcomas and other cancers
Twitter: @BenNacev
30 September
Ana Banito
German Cancer Research Center
Mechanistic insights into SS18-SSX-driven synovial sarcoma
Twitter: @SoftSarcoma
7 October
Wolf Fridman
Cordeliers Research Centre, INSERM
B cells and Tertiary Lymphoid Structures predict survival and immunotherapy response in Soft Tissue Sarcoma
14 October
Vivek Subbiah
MD Anderson Cancer Center
Precision Oncology in Sarcomas: Divide and Conquer
Twitter: @VivekSubbiah
28 October
Sophie Postel-Vinay
Institut Gustave Roussy
Insights into Desmoplastic Small Round Cell Tumour biology through single cell sequencing
4 November
Torsten Nielsen
University of British Columbia
Sarcoma molecular diagnostics - the new generation of techniques entering clinical practice
11 November
Priya Chudasama
German Cancer Research Center
National Center for Tumor Diseases, Heidelberg
Molecular mechanisms and drug targets in Leiomyosarcoma
Twitter: @priyachudasama5